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Background: The aims were to identify predictors of treatment retention in methadone maintenance treatment
(MMT) clinics in Pearl River Delta, China.
Methods: Retrospective longitudinal study. Participants: 6 MMT clinics in rural and urban area were selected.
Statistical analysis: Stratified random sampling was employed, and the data were analyzed using Kaplan-Meier
survival curves and life table method. Protective or risk factors were explored using Cox’s proportional hazards
model. Independent variables were enrolled in univariate analysis and among which significant variables were
analyzed by multivariate analysis.
Results: A total of 2728 patients were enrolled. The median of the retention duration was 13.63 months, and the
cumulative retention rates at 1,2,3 years were 53.0%, 35.0%, 20.0%, respectively. Multivariate Cox analysis showed:
age, relationship with family, live on support from family or friends, income, considering treatment cost suitable,
considering treatment open time suitable, addiction severity (daily expense for drug), communication with former
drug taking peer, living in rural area, daily treatment dosage, sharing needles, re-admission and history of being
arrested were predictors for MMT retention.
Conclusions: MMT retention rate in Guangdong was low and treatment skills and quality should be improved.
Meanwhile, participation of family and society should be encouraged.
Keywords: Methadone maintenance treatment, Retention, Cox’s proportional hazards modelBackground
Heroin addiction is chronic relapsed encephalopathy
and so far there is no treatment to cure. International
evidence-based practices have proved that Methadone
maintenance treatments (MMTs) are effective to reduce
heroin use and high-risk behaviors, as well as to prevent
transmission of HIV and HCV [1-4]. Since the appear-
ance of HIV infection, MMTs have been pushed forward,
and they have been proved helpful in reducing both drug
use and the transmission of infectious diseases, such as
HIV or viral hepatitis [5].
In consideration of epidemic of HIV among drug users,
China initiated MMT in Yunnan, Sicuan, Zhejiang,* Correspondence: fangyll@21cn.com
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reproduction in any medium, provided the orGuizhou and Guangxi provinces in 2004 with 8 MMT
clinics established .With the success of the pilot MMT
clinics, 680 MMT clinics were established by the end of
2009 nationwide, 241975 patients were recruited accumula-
tively, and the retention rate was 65%. Meanwhile,
56 MMT clinics were established by the end of 2009 in
Guangdong,19442 patients were recruited accumulatively,
and the retention rate was 57.4%.The retention rate in
Guangdong was low and a lot of patients had dropped out.
According to the Chinese Implementation Protocol for
Community-Based Methadone Maintenance Treatment for
Opiate Addicts, the eligibility criteria to participate in
MMT were: (i) clients who are addicted to opiate according
to addiction protocol; (ii) at least 20 years of age; (iii) the
number of allowable missing treatment days was 7 con-
secutive days; and (iv) capable of complete civil liability.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Yang et al. Harm Reduction Journal 2013, 10:3 Page 2 of 7
http://www.harmreductionjournal.com/content/10/1/3Drug users testing HIV-positive needed only to fulfil re-
quirement (i). Furthermore, a detailed clinical guideline for
methadone treatment was added to the protocol to support
clinical practice and comprehensive interventions were
highlighted in the new protocol which suggested clinics of-
fering ancillary services. These included counseling, psy-
chosocial support, testing for HIV, syphilis, hepatitis C and
tuberculosis, referrals for antiretroviral treatment, peer
education, health education, group activities, social support
and skills training for employment. The treatment fee for
MMT services was not specified, as in some areas where
heroin is easily obtained at low cost, the fee is reduced or
even waived [6].
One principal target of MMT was to keep patients
under treatment, by which, patients can receive treat-
ment concerning psychology, behavior and personality.
The patients dropped out are more likely to relapse or
engage in high-risk behaviors contracting HIV [7].
The aim of this paper was to employ generalized sur-
vival in the analysis of MMT retention, to explore the
factors associated with retention in MMT among drug
users in Pearl River Delta region, Guangdong province.
Methods
Study sites and participants
Retrospective longitudinal study was carried out. There
were a total of 56 MMT clinics in Guangdong until
September 30th in 2010, among which 31 clinics were lo-
cated in Pearl River Delta region, 17 clinics in urban area
and 14 clinics in rural area. Stratified random sampling
was employed to select the clinics for this study. In
accordance with the urban and rural classification, 3 clinics
in urban and rural areas were selected respectively.
Among the 6 clinics Liuhua Hospital of Shenzhen Prefec-
ture, Third People’s Hospital of Foshan Prefecture and
Guangzhou Prefectural Psychosis Hospital were in urban
area; and Conghua Chronic Hospital of Guangzhou, Taihe
Hospital of Taishan County and Xiaogang Hospital of
Xinhui County were in rural area. All the patients (2728
individuals) who were enrolled between January in 2006
and September in 2010 in the selected MMT clinics
in Pearl River Delta of Guangdong were recruited. Patients
who were enrolled in other MMT clinics and temporally
referred to the 6 clinics were not included in the
present study.
Data collection
The data including socio-demographic, testing, treat-
ment and drug abuse history of the subjects in the 6
MMT clinics were obtained from the National AIDS In-
formation System. All the databases were linked by the
unique treatment serial number. Study variables in-
cluded socio-demographic, drug taking history, clinical
treatment, testing and illegal behaviors, etc.The definition of retention encompassed : (1) patients
remaining in MMT along the period of study; (2) pa-
tients who were temporarily referred to other MMT
clinic other than the selected 6 clinics;(3) the period of
study referred to duration between January 1st, 2006 and
September 30th, 2010.
Retention duration is calculated from first MMT entry
and up to the date patients dropped out of treatment or
the end of the follow-up period (September 30th, 2010).Statistical analyses
Pearson X2 test was employed to analyze classified vari-
ables. The number of months in MMT clinic from first
admission until the patient’s quit for treatment or until
the end of follow-up was taken for calculating retention
duration in treatment using Kaplan-Meier method. Life
table method was used to calculate the cumulative
retention rate. Cox’s proportional hazards model was
employed to define the factors associated with retention
in MMT. 21 independent variables including socio-
demographic, drug taking history, clinical treatment,
testing, follow up and illegal behaviors were enrolled
in univariate analyses, of which variables significantly
associated with retention (p-value < 0.05) were selected
into the Cox regression multivariate analyses. Hazard
Ratio (HR) and 95% confidence interval were presented.
All independent variables are transformed into categor-
ical variables. All analyses were done by using the SPSS-
17.0 package.Results
Sample description
The patients’ characteristics were detailed in Table 1. A
total of 2728 patients were recruited, among which the
mean age at first MMT entry was 36.4 years (S.D.=12.4
years). The majority of patients were males (72.8% com-
pared to 27.2% females), 420 (15.4%)were less than 30
years, 1329 (48.7%)were unmarried, 1456 (53.4%) sub-
jects were from urban area, 2181 (79.9%)were under
elementary school educated, 1495 (54.8%) were un-
employed, only a few of patients were in good relation-
ship with family (18.0%), and 1293 (47.4%) living with
family or friends. 560 (20.5%) initiated drug use less than
20 years old and 1537 (56.3%) had been taking drugs
over 10 years. 322 (48.5%) had experience of being
arrested. 567 (20.8%) subjects had been in treatment
over 2 years, 1145 (42.0%) participants’ daily methadone
treatment dosage was over 50mg, and 1288 (47.2%) per-
ceived satisfaction with MMT services. 1103 (40.4%)
subjects in treatment was tested positive for urine mor-
phine. The accumulative retention rate was only 22.3%
(607 individuals) (See Table 1).
Table 1 Characteristics of Patients’ in methadone




Gender** male 2448 89.7
female 280 10.3
Age(years) * ≤30 420 15.4
>30 2308 84.6
Marital status single 1329 48.7
married 1399 51.3
Education years** <6 2181 79.9
7-12 481 17.6
>12 66 2.4
Employment no 1495 54.8
yes 1233 45.2
Relationship with family** bad 2238 82.0
good 490 18.0
Living with family or friends** no 1435 52.6
yes 1293 47.4
Initial drug use age ≤20 560 20.5
21~30 1886 69.1
>30 282 10.3
Re-admission no 1406 51.5
yes 1322 48.5
Daily drug use times pre-admission ≤3 2218 81.3
>3 510 18.7
Drug use years pre-admission* ≤5 367 13.5
6~10 816 29.9
>10 1537 56.3
Needle sharing experience* no 2333 85.5
yes 395 14.5
Urban residence** no 1272 46.6
yes 1456 53.4
Daily dosage(mg)** ≤30 688 25.2
31~50 895 32.8
>50 1145 42.0
History of being arrested** no 1406 51.5
yes 1322 48.5








Urine morphine test** negative 1625 59.6
positive 1103 40.4
Considering treatment cost suitable** no 1449 53.1
Table 1 Characteristics of Patients’ in methadone
maintenance treatment clinics and relations to treatment
retention (n=2728) (Continued)
yes 1279 46.9
Drug use cost pre-MMT admission ≤300 2122 77.8
>300 606 22.2
Duration of MMT treatment(years) ** ≤1 1616 59.2
1 <&≤2 545 20.0
>2 567 20.8
MMT treatment outcome retained 607 22.3
Drop-out 2121 77.7
Note: (*) For statistically significant differences to MMT retention p<0.05; (**)
For statistically significant differences to MMT retention p<0.01.
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Retention as dependant variable and socio-demographic,
drug taking history, clinical treatment, testing, follow up
and illegal behaviors etc. as independent variables were
introduced into the Univariate Cox’s proportional haz-
ards model. The analyses showed that age group, resi-
dence in urban or rural area, income, living with family
or friends, relationship with family, duration of taking
drug prior to MMT admission, sharing needles, attitude
towards treatment fee, attitude towards treatment open
time, addiction severity(daily expense for taking drug
pre-admission), re-enrolled history, treatment dosage,
history of being arrested, communication with former
drug taking peer last month, satisfaction toward MMT
service were associated with MMT retention signifi-
cantly (p<0.05) (see Table 2).
Multivariate Cox’s proportional hazards model analyses
The variables which were significantly associated with re-
tention (P<0.05) in univariate Cox’s analyses were selected
into multivariate Cox’s proportional hazards model analyses
to define the predictors of MMT retention. The multivari-
ate analyses showed that admission age over 30 years old
(HR=0.78, 95% CI=0.69~0.88), keeping good relationship
with family (HR=0.68, 95% CI=0.58~0.80), living on sup-
port from family or friends(HR=0.4, 95% CI=0.3~0.5), living
on permanent income(HR=0.40, 95% CI=0.30~0.54), living
on casual income(HR=0.43, 95% CI =0.33~0.55), living on
social welfare(HR=0.41, 95% CI=0.23~0.72), considering
treatment cost suitable (HR=0.71, 95% CI=0.60~0.84), con-
sidering treatment open time suitable (HR=0.73, 95%
CI=0.62~0.87), daily cost for taking drug pre-admission less
than 300 RMB¥ (HR=0.80,95% CI=0.71~0.90) and no com-
munication with former drug taking peer within last month
(HR=0.90, 95% CI=0.84~0.98) were protective factors for
retention; whereas, living in rural area (HR=1.12, 95%
CI=1.01~1.25), daily treatment dose less than 30 mg
(HR=1.44, 95% CI=1.29~1.61), daily treatment dose is
Table 2 Cox’s proportional hazards model analyses on factors associated with MMT retention duration
Variables Assignment Univariate analyses Multivariate analyses
HR HR 95.0% CI HR HR 95.0% CI
Age group(year)( ≤30=0)
>30 1 0.69** 0.62~0. 77 0.78** 0.69~0.88
Residence(urban=0)
rural 1 1.25** 1.20~1.30 1.12* 1.01~1.25
income(others=0)
family or friends 1 0.19** 0.17~0.21 0.40** 0.31~0.52
fixed income 2 0.21** 0.18~0.24 0.40** 0.30~0.54
temporary income 3 0.20** 0.18~0.22 0.43** 0.33~0.55
social welfare 4 0.17** 0.11~0.26 0.41** 0.23~0.72
Living with family or friends(yes=0)
other 1 5.50** 4.84~6.23
Relationship with family(bad=0)
good 1 0.31** 0.29~0.34 0.68** 0.58~0.80
Drug use years pre-admission(years) (>10=0)
≤5 1 1.14* 1.02~1.28
6~10 2 1.13** 1.04~1.23
Sharing needles(no=0)
yes 1 1.25** 1.12~1.39 1.23* 1.08~1.40
Considering treatment cost suitable(no=0)
yes 1 0.35** 0.32~0.38 0.71** 0.60~0.84
Considering treatment operation time suitable(no=0)
yes 1 0.27** 0.25~0.30 0.73** 0.62~0.87
Daily expense for drug (RMB¥)prior to MMT(>300=0)
≤300 1 1.21** 1.10~1.33 0. 80** 0.71~0.90
Re-enrolled(no=0)
yes 1 1.49** 1.42~1.56 1.41** 1.34~1.49
History of being arrested(no=0)
yes 5.43** 4.96~5.96 1.35** 1.08~1.69
Daily treatment dosage(mg)(>50=0)
≤30 1 1.25** 1.14~1.38 1.44** 1.29~1.61
31~50 2 1. 27** 1.17~1.39 1.33** 1.21~1.48
Communication with former drug taking peers last month(yes=0)
no 1 0.60** 0.57~0.63 0.90** 0.84~0.98
Satisfaction with MMT service(no=0)
yes 1 0.23** 0.20~0.25
Note:MMT outcome assignment: Retention =0,drop-out=1.
* Statistically significant (p<0.05).
** Statistically significant (p<0.01).
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needles(HR=1.23, 95% CI=1.08~1.40), re-admission in
MMT(HR=1.41, 95% CI=1.34~1.49)and history of being
arrested(HR=1.35, 95% CI=1.08~1.69)were risking factors
for MMT retention (P <0.05) (see Table 2).MMT retention duration and retention rate
MMT retention duration was calculated by using Kaplan-
Meier method. The median of the retention duration from
the date when a patient first received MMT to the date
when the patient dropped out or when the study expired
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The minimum and maximum of the retention durations
were 0.33 and 56.63 months, respectively. The cumulative
retention rates were analyzed by life table method, and the
rates at 1, 2, and 3 years were 53.0%, 35.0%, and 20.0%,
respectively.Discussion
Retention duration and retention rate
Retention rate and duration were the most important in-
dicators to evaluate MMT [8]. This study showed that
the median of retention duration was 13.63 months,
which was less than the one (23 months) from the study
in New York [9] but was longer than the ones from the
studies in Italia (7 months) [10] and Urumqi (2.5 months)
[7]. In addition, the retention duration in our study was
consistent with the study in Spain and other sites
[7,11,12]. While the cumulative retention rates at 1,2 and-
3 years are 53.0%, 35.0% , 20.0%, respectively, which were
far less than the ones shown by study carried out in
Jiangsu province where retention rates at 1–2 years are
72.8%, 52.7% , respectively [13]. It was also less than 1 year
retention rate (74.4%) shown by study in other country
[14]. However it was longer than the study in Urumqi (
46.9% after 9 months) [7,12]. There were a variety of fac-
tors which had effects on MMT retention rate [15]. The
longer patients stayed in MMT clinic and no longer
dependent on opioids, and receiving more supportive ser-
vices, the more likely for patients to get better treatment
outcome [9,16].Figure 1 MMT retention rate and retention durance in Pearl
River Delta, Guangdong, 2006.1-2010.9.Sociodemographic predictors for retention of MMT
Our study disclosed sociodemographic predictors for re-
tention MMT included: age at admission over 30 years
old, keeping good relationship with family, living on sup-
port from family or friends, living on permanent income,
living on casual income, living on social welfare, daily
cost for taking drug pre-admission less than 300 RMB¥,
living in rural area, sharing needles and history of being
arrested. All the predictors above were statistically sig-
nificantly (P<0.05).
As age [6,17,18], income [17], addiction [19] and crime
[9] were concerned, our findings were consistent with
the studies carried out in other countries [6,9,17-19].
The common findings showed that age at admission in
MMT over 30 years old, stable income, less crimes, no
needle sharing and light addiction (daily expense for
drug ≤300 RMB¥ pre-admission) were protective factors
for MMT retention.
We found that criminal history was negatively associ-
ated with longer retention duration, and the group with
history of being arrested had less retention duration
than ones who had not. This finding was consistent with
the study implemented in New York City (9).
Our study disclosed that the subjects lived in rural
areas were more likely to drop out than those in urban
areas. This was possibly due to lack of social supports
and poor economic status in the countryside. There was
a big difference between urban and rural areas not only
in terms of sociodemographic factors but also the
skills of medical staff in MMT clinics, which in turn
influenced MMT maintenance retention.
Risking behaviors were negatively associated with
MMT retention, In our study, sharing needles was found
as risk factor for retention. The relationship should be
further studied about the interactions between sharing
syringe and the patients’ MMT related knowledge and
attitude.
In terms of family ties and social support, correlated fac-
tors included keeping good relationship with family
(HR=0.7, 95% CI=0.6~0.8), living on support from family
or friends(HR=0.4, 95% CI=0.3~0.5), living on social wel-
fare(HR=0.4, 95% CI= 0.2~0.7). This revealed the import-
ance of family ties and social support as to MMT retention
for patients. Family support could benefit the MMT clients
in many different ways. Family members could help previ-
ous drug users to make important decisions, such as enrol-
ling and remaining in the MMT programs. Thus, family
support could also have significant implications for the effi-
cacy of family-focused interventions and programming
[20]. Potentially, family members could act as advocates for
the policy, and encourage opioid users to participate in the
treatment programs and take medications on a long-term,
daily basis [20]. This echoed the findings in other research
that, in order to be successful, HIV-related services and
Yang et al. Harm Reduction Journal 2013, 10:3 Page 6 of 7
http://www.harmreductionjournal.com/content/10/1/3programs needed to involve families appropriately and ef-
fectively [21].
Predictors for retention of MMT concerning MMT service
Predictors for retention of MMTconcerning MMT service
included: daily treatment dose less than 50 mg, re-
admission in MMT were risk factors for MMT retention;
while considering treatment cost suitable, considering
treatment open time suitable, and no communication with
former drug taking peer within last month were protective
factors for MMT retention. All the predictors above were
statistically significantly (Table 2).
Daily dosage attracted much more attentions and many
studies were carried out to define the role of dosage
towards retention rate. Our finding on the applicability
of a high methadone dose to predict long-term retention
replicated the experience of others [10,14,22]. The rela-
tionship among opinions about MMT clinic open time
and treatment cost were also in accord with other studies
initiated in other place [23,24].
On the contrary, our findings differed from those con-
clusions drawn from studies in other countries in terms
of relationships between retention and experience of
drop-out [23] and communication with former drug
taking peers [7]. In our study, we found that having ex-
perience of drop-out and communication with former
drug taking peers were risk factors for MMT retention.
Findings of this study should be considered in light of
the following limitations. The data were drawn from a
Pearl River Delta sample only. The MMT programs and
clients in these areas might be different from those in
other parts of Guangdong province. One should be cau-
tious in generalizing the findings to other geographic lo-
cations and populations. Still, this study identified family
and social supports, daily treatment dose, etc. as predic-
tors of successful maintenance for methadone treatment.
Conclusions
In conclusion, we found that most of our findings were in
agreement with those of other studies in other countries
and regions. Revealed by our study, what should be em-
phasized was that MMT retention was associated with not
only treatment services, but also social supports. These
findings highlighted that for sake of improvement of
MMT retention and quality, we should not only improve
skills of MMT medical staff but also improve family ties
and social supports. Thus, for the service providers ongoing
training on psychological counseling, behavior intervention,
methadone pharmaceutics and dosage adjustment, etc.
were in urgent need. On the other hand, family members
and local communities should be recruited and educated
to facilitate the process of MMT in order to achieve a
higher rate of participation and compliance from commu-
nity opioid addicts.Abbreviations
MMT: Methadone maintenance treatment.
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